What is estimated in cluster randomized crossover trials with informative sizes? A survey of estimands and common estimators
Open Access
- 8 August 2026
- journal article
- research article
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 35 (9) , 1980-2000
Abstract
The cluster randomized crossover (CRXO) trial, among other multi-period cluster randomized trial designs, can target average treatment effect (ATE) estimands that equally weigh the contributions of individuals (iATE), clusters (cATE), cluster-periods (cpATE), or periods (pATE). With these weighted ATE estimands, we define different forms of informative sizes, where the treatment effects vary according to cluster, period, and/or cluster-period sizes, causing these estimands to differ. Under such informative sizes, we survey which of the unweighted, inverse cluster-period size weighted, inverse cluster size weighted, and inverse period size weighted: (i) independence estimating equation, (ii) fixed effects model, (iii) exchangeable mixed effects model, and (iv) nested exchangeable mixed effects model treatment effect estimators are consistent for the aforementioned estimands in cross-sectional CRXO designs with continuous outcomes. We demonstrate that with informative sizes, the unweighted and weighted nested exchangeable mixed effects model estimators are not consistent for any meaningful estimand and can yield biased results. In contrast, the unweighted and weighted independence estimating equation, and under specific scenarios, the fixed effects model and exchangeable mixed effects model, can yield consistent and empirically unbiased estimators for meaningful estimands in CRXO trials.Keywords
All Related Versions
Funding Information
- Patient-Centered Outcomes Research Institute (ME-2022C2-27676)
- National Health and Medical Research Council (GNT2033380)
- Medical Research Council (MC UU 00004/07)
- Medical Research Council (MC UU 00004/09)
This publication has 34 references indexed in Scilit:
- Analysis of Stepped‐Wedge Cluster Randomized Trials When Treatment Effects Vary by Exposure Time or Calendar TimeStatistics in Medicine, 2025
- How Should Parallel Cluster Randomized Trials With a Baseline Period be Analyzed?—A Survey of Estimands and Common EstimatorsBiometrical Journal, 2025
- Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical VentilationJAMA, 2020
- How many times should a cluster randomized crossover trial cross over?Statistics in Medicine, 2019
- Using simulation studies to evaluate statistical methodsStatistics in Medicine, 2019
- Power and sample size requirements for GEE analyses of cluster randomized crossover trialsStatistics in Medicine, 2018
- Stepped wedge designs: insights from a design of experiments perspectiveStatistics in Medicine, 2017
- Choosing appropriate analysis methods for cluster randomised cross‐over trials with a binary outcomeStatistics in Medicine, 2016
- Sample size calculation for cluster randomized cross‐over trialsStatistics in Medicine, 2008
- Analysis of cluster randomized cross‐over trial data: a comparison of methodsStatistics in Medicine, 2006